NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

NHS Greater Glasgow and Clyde Area Drug and Therapeutics Committee


NHS Greater Glasgow & Clyde

GGC Medicines



GGC Medicines has been designed as a tool to assist in promoting high quality, safe and cost-effective prescribing within the Greater Glasgow and Clyde Health Board.  The website has useful resources for prescribers and patients including:

  • The GGC Adult Medicines Formulary as a searchable or navigational database
  • The Adult Therapeutics Handbook: an essential resource for junior medical staff working in NHSGGC
  • Current prescribing and clinical information via the Medicines Update suite of publications
  • Information for patients on access to medicines
  • Policies relating to medicines in NHSGGC
  • Other formularies

Latest news:

GGC Medicines App available for iPhone®, iPad® and Android® phones and tablets

  • The GGC Medicines App is now available to download for free!
  • The app contains the Adult Therapeutic Handbook, access to the Medicines Update suite of bulletins, access to the GGC Adult Formulary and dosing calculators for gentamicin and vancomycin in adults in NHSGGC.
  • NOTE FOR ANDROID USERS: In order to display the flowcharts in the app, you must have an app that is capable of opening PDF files installed on your device, for example 'Adobe Reader', which is free to download from Google Play.
  • If you have an Android device that cannot access Google Play (e.g. Amazon Fire tablet), please contact us and we can email you the installation file directly.

Download the GGC Medicines App for iOS here Download the GGC Medicines App for Android



THERAPEUTICS HANDBOOK (December 2014): The PDF of the Handbook has been updated to reflect the changes made to the content in the GGC Medicines App.  The GGC Medicines app will continue to be the source of the most up-to-date guidance.

DOMPERIDONE (April 2014): Following a Europe-wide review, the MHRA issued advice to healthcare professionals relating to the use of domperidone, restricting its use to relief or nausea and vomiting, advising that it should be used at the lowest effective dose for the shortest possible time, and highlighting changes to the contraindications, dosing and duration of treatment of the medicine. The full advice from the MHRA can be accessed here.